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://dSummary
Cancer registries are valuable sources for epidemiological research investigating risk factors underlying
different types of cancer incidence. The present study is based on the Swiss Feline Cancer Registry that com-
prises 51,322 feline patient records, compiled between 1965 and 2008. In these records, 18,375 tumours were
reported. The study analyses the influence of sex, neutering status, breed, time and age on the development of
the most common tumour types and on their locations, using a multiple logistic regression model. The largest
differences between breeds were found in the development of fibrosarcomas and squamous cell carcinomas, as
well as in the development of tumours in the skin/subcutis and mammary gland. Differences, although often
small, in sex and neutering status were observed in most analyses. Tumours were more frequent in middle-
aged and older cats. The sample size allowed detailed analyses of the influence of sex, neutering status, breed
and age. Results of the study are mainly consistent with previous analyses; however, some results cannot be
compared with the existing literature. Further investigations are necessary, since feline tumours have not
been investigated in depth to date. More accurate comparisons would require the definition of international
standards for animal cancer registries.
 2016 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Keywords: cancer registry; cat; statistical analysis; tumourIntroduction
Cancer registries are important tools for establishing
cancer control and prevention strategies. They are
used in epidemiological research to examine risk fac-
tors underlying the incidence of different types of can-
cer. Tumour initiation and progression are influenced
by several factors whose precise interactions are still
unknown.ondence to: A. Pospischil (e-mail: apos@vetpath.uzh.ch).
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 2016 The A
CC BY-NC-NDemographic variables such as sex, age (Parkin,
2006) and breed (Dorn et al., 1968b; Thrusfield,
2007) are typically used to analyse the development
of specific cancers.
Companion animals with spontaneously devel-
oping tumours are, moreover, valuable resources for
investigating the complexity of human cancer patho-
genesis, progression and therapy. Pets and people
share the same environment and are therefore
exposed to similar risk factors. Furthermore, their tu-
mours undergo analogous genetic and molecular al-
terations and they display similar levels of tumouruthors. Published by Elsevier Ltd. This is an open access article under the
D license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
196 R. Graf et al.heterogeneity, which results in similar mechanisms of
cancer development, resistance to therapy, recur-
rence and metastasis (Dorn et al., 1968a; Thrusfield,
1988; MacEwen, 1990; Paoloni and Khanna, 2008).
Finally, in-depth examination of animal tumours
could lead to the identification of new genes associ-
ated with cancer, relevant environmental risk factors
and the development of new prognostic, diagnostic
and therapeutic applications (Vail and MacEwen,
2000).
The present study is based on analysis of the Swiss
Feline Cancer Registry, which consists of 51,322
feline patient records compiled between 1965 and
2008 (Graf et al., 2015). In this extended examination
of data from the registry, we analyse the influence of
sex, neutering status, breed and age on the develop-
ment of themost common feline tumour types (i.e. ad-
enoma/adenocarcinoma, fibrosarcoma, lymphoma
and squamous cell carcinoma) and tumour locations
(i.e. skin and subcutis, mammary gland, gastrointes-
tinal tract, cardiorespiratory system and oral cavity/
pharynx), their distribution and relative frequency
over the period of study.Materials and Methods
Data from the Swiss Feline Cancer Registry (Graf
et al., 2015) were used for extended analysis. Three
veterinary diagnostic laboratories in Switzerland pro-
vided the case records.
Feline breeds with at least 90 individual records
were investigated further; the remaining breeds
were classified as ‘other breeds’. The sex of the ani-
mals was grouped as following: male, neutered
male, female, neutered female and unknown.
To unify the classification of some of the anatom-
ical locations, we changed two specifications: leucosis
with the location ‘bone marrow’ was changed to the
location ‘unknown’ and fibrosarcomas with the loca-
tion ‘skin’ were changed to the location ‘soft tissue’
(subcutis).
Since there is no obligatory registration of cats in
Switzerland, there are only approximate estimates
of the size of the feline population. Therefore, propor-
tional calculations from the available patient datasets
are given.
Data, wherever applicable, were analysed in two
groups. In the first group all tumours (i.e. benign
and malignant together) were analysed and in the
second group only malignant tumours were included.
Using ICD-0-3 for human patients (WHO, 2013),
tumour names were sometimes slightly different from
those used in veterinary pathology (i.e. malignant
lymphoma, mast cell sarcoma and fibromatous
neoplasia). ‘Basal cell tumour’ is also an old term,which is now usually replaced with the terms ‘tricho-
blastoma’ or ‘sweat gland ductular adenoma’.
Data editing and statistical analyses were per-
formed using Stata Software (StataCorp, 2011; Stata
Statistical Software: Release 12; StataCorp, College
Station, Texas, USA). Statistical analyses were car-
ried out using Chi-square/Fisher’s exact test. Signifi-
cant variables were further integrated and analysed
in a multiple logistic regression model (using binary
logistic models and stepwise backward procedure).
The following variables were included in the final
model as fixed terms: canton of origin, age, sex/neu-
tering status, breed, year and method of examination.
P# 0.05 was considered to be significant and odds ra-
tios (ORs) with 95% confidence intervals (CIs) were
calculated. The power was set at >0.8.Results
The Swiss Feline Cancer Registry consists of the re-
cords of 51,322 cats that underwent pathological ex-
amination. The number of patients with confirmed
tumours was 17,856 (34.79%). Some cats were diag-
nosed with multiple primary tumours, adding up to
a total of 18,375 diagnosed tumours. Of these diagno-
ses, 14,759 (80.32%) tumours were malignant.
Most cats were of the European shorthair breed. In
the statistical evaluation, this breed was used as the
standard for comparisons with the remaining breeds.
Breed, sex and age distribution of the entire dataset
are presented in Graf et al. (2015).
The following results introduce the most common
tumour types and anatomical locations in cats, the in-
fluence of age, breed and sex, as well as occurrence
over the years.Adenoma/Adenocarcinoma
Adenoma/adenocarcinoma was the most common
tumour diagnosed between 1965 and 2008. Among
the 18,375 diagnosed tumours, 3,515 (19.1%) were
either an adenoma or an adenocarcinoma. Of the to-
tal number, 2,613 (74.3%) were malignant (adeno-
carcinomas). In the 1960s, approximately half of the
diagnosed tumours were adenomas/adenocarci-
nomas. Their relative frequency decreased over the
period covered by this study (Fig. 1).
The most common anatomical locations of ade-
noma/adenocarcinoma and adenocarcinoma were
the mammary gland, gastrointestinal tract and
cardiorespiratory tract (Fig. 2).
Using multiple logistic regression analysis, the odds
of cat breeds developing an adenoma/adenocarci-
noma were compared with those of the European
shorthair cat (OR ¼ 1). Two analyses were carried
Fig. 1. Relative diagnosis frequency of adenoma (n ¼ 902) and
adenocarcinoma (n ¼ 2,613) expressed as a percentage of
the overall tumour diagnoses (n ¼ 18,375) between 1965
and 2008.
Swiss Feline Cancer Registry 197out, one using the group adenoma/adenocarcinoma
(benign and malignant) and one using only adeno-
carcinomas (malignant) (Fig. 3). In both analyses,
only a few breeds had higher odd ratios in comparison
with European shorthair cats. Siamese cats
(OR ¼ 2.44 [2.07, 2.89]) and Oriental shorthair
cats (OR¼ 2.86 [1.45, 5.61]) had the highest odds ra-
tios when frequency of adenocarcinoma was calcu-
lated (see Supplementary data).
Analyses of the influence of age revealed that
the odds of cats developing an adenoma/adeno-
carcinoma or adenocarcinoma increased with
age. The odds of a neutered male cat developing
an adenoma/adenocarcinoma or adenocarcinoma
were significantly higher compared with entire
male cats. There was no significant difference be-Fig. 2. Most common anatomical locations of adenoma/adenocarcinotween neutered and entire female cats. The odds
of a female cat developing an adenoma/adeno-
carcinoma or adenocarcinoma compared with
those of a male cat were significantly higher
(Table 1).Fibroma/Fibrosarcoma
Of 18,375 diagnosed tumours, 3,386 (18.4%) were
either a fibroma or a fibrosarcoma. Of these, 3,209
(94.8%) were malignant. Fibroma/fibrosarcoma
was a rare diagnosis in the 1960s, but its relative fre-
quency has increased since. This is especially true
starting from the 1990s, where fibroma/fibrosarcoma
occurrences increased substantially (Fig. 4).
Because fibromas were rare and have no important
effect on the analyses, further investigations focused
on fibrosarcomas only. Themost common anatomical
locations for fibrosarcomawere the connective tissues,
including subcutis (skin) with 88.5%, followed by un-
known location (5.7%) and oral cavity/pharynx
(3.1%).
No breed had significantly higher odds of devel-
oping a fibrosarcoma compared with the European
shorthair cat (OR ¼ 1). However, several breeds
had odds ratios that were significantly lower (Fig. 5)
(see Supplementary data).
Analyses of the influence of age revealed that fibro-
sarcomas occurred more frequently in middle-aged
and older cats. Neutered and entire male cats had
the same odds of developing a fibrosarcoma.Neutered
female cats had significantly higher odds than entire
female cats. The odds of a female cat developing a
fibrosarcoma compared with those of a male cat
were significantly higher (Table 1).ma (n ¼ 3,515; left) and adenocarcinoma (n ¼ 2,613; right).
Fig. 3. Odds ratios (ORs) and 95% confidence intervals (CIs) for the most common breeds that develop adenoma/adenocarcinoma
(benign and malignant, n ¼ 3,515) or adenocarcinoma (malignant, n ¼ 2,613) compared with the European shorthair cat
(OR ¼ 1).
Table 1
Odds ratios (ORs) and 95% confidence intervals (CIs) for the most common tumour types comparing sex and neutering
status
Tumour type Male neutered versus male entire (OR ¼ 1) Female neutered versus female entire (OR ¼ 1) Female versus male (OR ¼ 1)
OR (95% CI) P OR (95% CI) P OR (95% CI) P
Adenoma/
adenocarcinoma
1.53 (1.34, 1.75) 0.00 0.95 (0.87, 1.05) 0.31 2.15 (2.00, 2.31) 0.00
Adenocarcinoma 1.53 (1.30, 1.80) 0.00 0.99 (0.89, 1.10) 0.83 2.62 (2.40, 2.87) 0.00
Fibrosarcoma 1.01 (0.90, 1.14) 0.83 1.26 (1.13, 1.41) 0.00 1.12 (1.04, 1.21) 0.00
Lymphoma 1.37 (1.22, 1.54) 0.00 1.49 (1.31, 1.68) 0.00 0.88 (0.81, 0.95) 0.00
Squamous cell
carcinoma
1.32 (1.13, 1.54) 0.00 1.30 (1.12, 1.5) 0.00 1.01 (0.92, 1.11) 0.19
198 R. Graf et al.Lymphoma
Of 18,375 diagnosed tumours, 2,868 (15.6%) were
classified as lymphoma. This tumour type was rela-
tively frequent from 1972 to 1994, where up to 38%
of tumour diagnoses were of this type. In the mid-
1990s the frequency of lymphoma dropped substan-
tially and the relative frequencies have remained be-
tween 10% and 15% since (Fig. 6).
The most common anatomical locations for lym-
phoma were unknown location, gastrointestinal tract
and lymph node (Fig. 7).
Oriental shorthair and Somali cats had signifi-
cantly higher odd ratios for developing lymphomas
compared with those of European shorthair cats. Per-
sian, Maine Coon, British and Norwegian forest cats
had significantly lower odds ratios (Fig. 8) (see
Supplementary data).Analyses of the influence of age revealed that the
mean age of a cat developing lymphoma was 8.5
years. Lymphomas appeared in all age categories,
but were the most frequent tumour type in young
cats (<5 years) compared with other tumour types.
The odds of a neutered cat developing lymphoma
were significantly higher than for entire cats, for
both males and females. The odds of a female cat
developing lymphoma compared with those of a
male cat were significantly lower (Table 1).
Squamous Cell Carcinoma
Of 18,375 diagnosed tumours, 1,811 (9.9%) were
squamous cell carcinomas. The frequency of squa-
mous cell carcinomas constantly decreased between
the 1960s and the early 1990s and then increased
again (Fig. 9).
Fig. 6. Relative diagnosis frequency for lymphoma (n ¼ 2,868)
expressed as a percentage of overall tumour diagnoses
(n ¼ 18,375) between 1965 and 2008.
Fig. 4. Relative diagnosis frequency of fibroma (n ¼ 177) and
fibrosarcoma (n ¼ 3,209) expressed as a percentage of the
overall tumour diagnoses (n ¼ 18,375) during the years
1965e2008.
Swiss Feline Cancer Registry 199The most common anatomical locations for squa-
mous cell carcinomas were the skin (49.3%), followed
by the oral cavity/pharynx (29%) and unknown loca-
tion (9.7%). No other breed had significantly higher
odds of developing a squamous cell carcinoma than
the European shorthair cat (OR ¼ 1). However,
several breeds had significantly lower odds ratios
(Fig. 10) (see Supplementary data).
Analyses of the influence of age revealed that the
odds of developing a squamous cell carcinoma
increased with age, with a mean age at diagnosis of
12.2 years. The odds of a neutered cat developing aFig. 5. Odds ratios (ORs) and 95% confidence intervals (CIs) for
compared with the European shorthair cat (OR ¼ 1).squamous cell carcinoma were significantly higher
compared with entire cats, for both males and fe-
males. There was no significant difference between
the odds for female and male cats (Table 1).
Skin and Subcutis
Skin and subcutis were the most common anatomical
locations for tumours between 1965 and 2008. Of
18,375 diagnosed tumours, 7,629 (41.5%) were
located in the skin and subcutis. Of these, 5,804
(76.1%) were malignant. Benign skin and subcutane-
ous tumours had a frequency of around 10% betweenthe most common breeds that develop fibrosarcoma (n ¼ 3,209)
Fig. 7. Occurrences of the most common anatomical locations for lymphoma (n ¼ 2,868).
200 R. Graf et al.1965 and 2008. Malignant tumours increased in the
1990s from around 20% to almost 40% of the overall
tumour findings (Fig. 11).
The most common tumour types affecting the skin
and subcutis were fibrosarcoma, basal cell tumours
and squamous cell carcinoma (Fig. 12).
The European shorthair cat (OR ¼ 1) had the
highest odds of developing a tumour in the skin/sub-
cutis; several breeds had significantly lower odds ra-
tios (Fig. 13). In the evaluation of the skin withoutFig. 8. Odds ratios (ORs) and 95% confidence intervals (CIs) for them
with the European shorthair cat (OR ¼ 1).the subcutis (n ¼ 4,970), similar results were seen
(see Supplementary data).
Analyses of the influence of age revealed that the
odds of a cat developing a tumour or a malignant
tumour of the skin or subcutis increased with age,
with a mean age at diagnosis of 10.5 years. Increasing
odds with age were also found for the location skin
(without subcutis), with a mean of 10.8 years. Differ-
ences in sex/neutering status for developing a tumour
of the skin skin/subcutis or skin were small (Table 2).ost common breeds that develop lymphoma (n¼ 2,868) compared
Fig. 9. Relative diagnosis frequency of squamous cell carcinoma
(n ¼ 1,811) expressed as a percentage of overall tumour
diagnoses (n ¼ 18,375) during the years 1965e2008.
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Of 18,375 diagnosed tumours, 1,501 (8.2%) were in
the anatomical location of the mammary gland. Of
these, 1,249 (83%) were malignant. The frequency
of mammary gland tumours compared with overall
tumour findings did not change substantially from
1965 to 2008 (Fig. 14).
The most common mammary tumour types were
adenoma/adenocarcinoma (83.08%), fibromatous
neoplasia (3.8%) and epithelial neoplasia not other-
wise specified (NOS) (3.6%). AdenocarcinomaFig. 10. Odds ratios (ORs) and 95% confidence intervals (CIs) for
(n ¼ 1,811) compared with the European shorthair cat (OR(91.4%) and epithelial neoplasia NOS (2.4%) were
found most often when comparing malignant tu-
mours only.
No breed had significantly lower odds of devel-
oping a mammary tumour/malignant tumour than
the European shorthair cat (OR ¼ 1). However,
several breeds had significantly higher odds ratios
(Fig. 15) (see Supplementary data).
Analyses of the influence of age revealed that the
highest odds ratios of developing a tumour/malignant
tumour in the mammary gland were in cats aged
8e16 years. Neutered and entire male cats had no sig-
nificant differences in the odds of developing a
tumour/malignant tumour in the mammary gland.
Neutered female cats had significantly lower odds
than entire female cats in both analyses. The odds of
a female cat developing a tumour/malignant tumour
in the mammary gland compared with a male cat
were much higher (Table 2).Gastrointestinal Tract
Of 18,375 diagnosed tumours, 1,373 (7.5%) were in
the gastrointestinal tract. Of these, 1,196 (87.1%)
were malignant. Due to the fact that benign tumours
in the gastrointestinal tract were rare and had no
important effect on the analyses, further investiga-
tions focused on malignant tumours only. The fre-
quency of malignant tumours in the gastrointestinal
tract compared with the overall tumour locations
decreased from 1965 to 2008 (Fig. 16).the most common breeds that develop squamous cell carcinoma
¼ 1).
Fig. 11. Relative diagnosis frequency of skin and subcutaneous tu-
mours expressed as a percentage of the overall tumour di-
agnoses between 1965 and 2008. Malignant tumours of
the skin/subcutis (n ¼ 5,804) and benign tumours of the
skin/subcutis (n ¼ 1,825).
202 R. Graf et al.Exploring inmore detail the segments of the gastro-
intestinal tract: 50.2% of the malignant tumours were
in the intestine, 27.8% in the liver and gallbladder,
13.6% in the pancreas, 6.3% in the stomach, 1.5%
in the anal region and 0.75% in the oesophagus.
The most common malignant tumours in the
gastrointestinal tract overall were adenocarcinomas
and lymphoma (Fig. 17). In the intestine, the most
common malignant tumours were lymphoma
(40.7%), adenocarcinoma (40%) and sarcoma
(7.3%).
Persian (OR ¼ 0.64 [0.48, 0.84]) and Maine Coon
(OR ¼ 0.45 [0.22, 0.91]) cats had significantly lower
odds of developing a malignant tumour in the gastro-
intestinal tract compared with the European short-
hair cat (OR ¼ 1). Siamese (OR ¼ 1.45 [1.12,
1.87]) cats were the only breed with significantly
higher odds (Fig. 18) (see Supplementary data). For
evaluation of the intestine only: Siamese
(OR ¼ 1.92 [1.40, 2.64]), Chartreux (OR ¼ 2.65Fig. 12. Occurrence of the most common tumour types in the skin an
(n ¼ 5,804; right).[1.39, 5.02] and Somali (OR ¼ 3.41 [1.25, 9.36])
cats had significantly higher odds and Persian
(OR ¼ 0.5 [0.32, 0.76]) and Maine Coon (no
tumour) cats had significantly lower odds of devel-
oping a malignant tumour in the intestine compared
with European shorthair cats (see Supplementary
data).
Analyses of the influence of age revealed that the
odds of developing a malignant tumour in the gastro-
intestinal tract increased with age, with a mean age at
diagnosis of 11.2 years. Cats aged 10e14 years (mean
10.8 years) had the highest odds of developing a ma-
lignant tumour in the intestine. The odds of a neu-
tered cat developing a malignant tumour in the
gastrointestinal tract were significantly higher
compared with entire cats, for both males and fe-
males. There was no significant difference between
the odds for female and male cats (Table 2). Analyses
of intestinal tumours also revealed higher odds for
neutered cats, but no significant differences in the
male/female comparison (Table 2).Cardiorespiratory System
Of 18,375 diagnosed tumours, 1,223 (6.7%) were in
the cardiorespiratory system. Of these, 1,050
(85.9%) were malignant. Due to the fact that benign
tumours in the cardiorespiratory system were rare
and had no important effect on the analyses, further
investigations focused on malignant tumours only.
The frequency of malignant tumours in the cardiore-
spiratory system compared with overall tumour find-
ings did not change substantially from 1965 to 2008
(Fig. 19).
Most malignant tumours of the cardiorespiratory
system derived from the lung/bronchus (70.2%) and
from the nasal cavity/middle ear (21.0%). The most
common malignant tumours in the cardiorespiratory
tract were adenocarcinomas, lymphomas and epithe-
lial neoplasia NOS (Fig. 20).d subcutis. All tumours (n ¼ 7,629; left) and malignant tumours
Fig. 13. Odds ratios (ORs) and 95% confidence intervals (CIs) for the most common breeds that develop benign or malignant tumours
(n ¼ 7,629) or malignant tumours (n ¼ 5,804) of the skin/subcutis compared with the European shorthair cat (OR ¼ 1).
Swiss Feline Cancer Registry 203Evaluation of the lung/bronchus only showed that
the most commonmalignant tumours were adenocar-
cinomas (48.3%), epithelial neoplasia NOS (22.1%)
and lymphoma (13.6%).
No other breed had significantly higher odds of
developing a malignant tumour in the cardiorespi-
ratory system compared with the European short-
hair cat (OR ¼ 1). Abyssinian (OR ¼ 0.24
[0.06, 0.95]) and Birman (OR ¼ 0.13 [0.02,
0.92]) cats had significantly lower odds ratios
(Fig. 21) (see Supplementary data). No significantTable
Odds ratios (ORs) and 95% confidence intervals (CIs) for th
malignant tumours or malignant tumours only we
Tumour location Male neutered versus male entire (OR ¼ 1) Fema
OR (95% CI) P
Skin and subcutis* 1.06 (0.98, 1.15) 0.15 1
Skin and subcutis† 1.08 (0.99, 1.18) 0.10 1
Skin* 1.09 (1.00, 1.20) 0.06 1
Skin† 1.13 (1.01, 1.27) 0.03 1
Mammary gland* 0.75 (0.46, 1.2) 0.23 0
Mammary gland† 0.86 (0.51, 1.5) 0.63 0
Gastrointestinal tract† 1.81 (1.50, 2.18) 0.00 1
Intestine† 1.61 (1.25, 2.07) 0.00 1
Cardiorespiratory
system†
1.95 (1.57, 2.43) 0.00 1
Lung/bronchus† 2.35 (1.78, 3.11) 0.00 2
Oral cavity/pharynx† 1.31 (1.05, 1.62) 0.02 1
*All tumours.
†Malignant tumours.breed differences were found in the location lung/
bronchus.
Analyses of the influence of age revealed that the
odds of developing a malignant tumour in the cardio-
respiratory system increased with age. The same
applied for the location lung/bronchus. The mean
age of developing a tumour in the location lung/bron-
chus was 11.2 years.
The odds of a neutered cat developing a malignant
tumour in the cardiorespiratory system were signifi-
cantly higher compared with entire cats, for both2
e most common anatomical locations, where benign and
re found, comparing sex and neutering status
le neutered versus female entire (OR ¼ 1) Female versus male (OR ¼ 1)
OR (95% CI) P OR (95% CI) P
.18 (1.1, 1.28) 0.00 1.04 (0.98, 1.09) 0.18
.26 (1.15, 1.37) 0.00 1.07 (1.01, 1.14) 0.02
.12 (1.03, 1.23) 0.01 1.00 (0.94, 1.07) 0.90
.21 (1.08, 1.35) 0.00 1.04 (0.97, 1.12) 0.27
.62 (0.55, 0.7) 0.00 21.17 (16.68, 26.86) 0.00
.69 (0.61, 0.79) 0.00 21.85 (16.73, 28.54) 0.00
.55 (1.29, 1.87) 0.00 0.92 (0.82, 1.04) 0.19
.36 (1.05, 1.76) 0.02 0.87 (0.74, 1.03) 0.1
.91 (1.56, 2.32) 0.00 1.17 (1.03, 1.32) 0.02
.22 (1.75, 2.82) 0.00 1.28 (1.11, 1.49) 0.00
.35 (1.08, 1.69) 0.01 0.84 (0.73, 0.96) 0.01
Fig. 14. Relative diagnosis frequency of mammary tumours
expressed as a percentage of overall tumour diagnoses
between 1965 and 2008. Malignant mammary tumours
(n ¼ 1,249) and benign mammary tumours (n ¼ 252).
204 R. Graf et al.males and females. The odds of a female cat devel-
oping a malignant tumour in the cardiorespiratory
system compared with a male cat were significantly
higher. The same was true for the location lung/bron-
chus (Table 2).Oral Cavity and Pharynx
Of 18,375 diagnosed tumours, 980 (5.3%) were in the
oral cavity/pharynx. Of these, 862 (88.0%) were ma-
lignant. Due to the fact that benign tumours in the
oral cavity/pharynx were rare and had no importantFig. 15. Odds ratios (ORs) and95%confidence intervals (CIs) for them
n¼ 1,501) in themammary glands or amalignant tumour (n¼
hair cat (OR ¼ 1).effect on the analyses, further investigations focused
on malignant tumours only. In the 1970s and 1980s,
the frequency of malignant tumours in the oral cav-
ity/pharynx compared with overall tumour findings
ranged between 0 and 4%. In the 1990s their fre-
quency increased and the relative frequencies have re-
mained between 3 and 7% ever since (Fig. 22).
The most common malignant tumours in the oral
cavity/pharynx were squamous cell carcinoma and
fibrosarcoma (Fig. 23).
No other breed had significantly higher odds of
developing a malignant tumour in the oral cavity/
pharynx compared with the European shorthair cat
(OR ¼ 1). Unknown breed (OR ¼ 0.82 [0.69,
0.99]), Siamese (OR ¼ 0.45 [0.26, 0.75]) and Abys-
sinian (OR ¼ 0.14 [0.02, 0.98]) cats had significantly
lower odds ratios (Fig. 24) (see Supplementary data).
Analyses of the influence of age revealed that the
odds of developing a malignant tumour in the oral
cavity/pharynx increased with age, with a mean age
at diagnosis of 12.2 years. The odds of a neutered
cat developing a malignant tumour in the oral cav-
ity/pharynx were significantly higher compared
with an entire cat, for both males and females. The
odds of female cats developing a malignant tumour
in the oral cavity/pharynx compared with male cats
were significantly lower (Table 2).Discussion
This study provides a more in-depth evaluation of
data contained within the Swiss Feline Cancerost commonbreeds that develop a tumour (benign andmalignant,
1,249) in themammary glands comparedwith theEuropean short-
Fig. 16. Relative diagnosis frequency of malignant tumours in the
gastrointestinal tract (n ¼ 1,196) expressed as a percent-
age of overall tumour diagnoses between 1965 and 2008.
Fig. 17. Occurrence of the most commonmalignant tumour types
(n ¼ 1,196) in the gastrointestinal tract.
Fig. 18. Odds ratios (ORs) and 95%confidence intervals (CIs) for them
intestinal tract (n ¼ 1,196) compared with the European shor
Fig. 19. Relative diagnosis frequency of malignant tumours in the
cardiorespiratory system(n¼ 1,050) expressedasapercent-
age of overall tumour diagnoses between 1965 and 2008.
Swiss Feline Cancer Registry 205Registry. The most common tumour types and their
locations were analysed with respect to possible influ-
ential variables, tumour distribution and frequency
over the period of study. Only results where compar-
isons with other studies are possible will be discussed.
However, it should be kept in mind that other regis-
tries have often used different methodologies, inclu-
sion criteria, tumour classifications and statistical
evaluations and comparisons should be interpreted
with caution. On the other hand, the data collected
in this study derive from a large number of samples,
which could explain why in some instances previously
unrecognized risk factors were uncovered. Another
reason for discrepancies with previous studies couldost commonbreeds that develop amalignant tumour of the gastro-
thair cat (OR ¼ 1).
Fig. 20. Occurrence of the most commonmalignant tumour types
(n ¼ 1,050) in the cardiorespiratory system.
206 R. Graf et al.derive from true differences in the genetic structure of
the Swiss cat population as compared with the popu-
lations of other studies.
Probably themost interesting results with respect to
the possible aetiology of tumours relate to the fre-
quencies of fibrosarcoma and lymphoma in this study.
Between 1965 and 1990, the frequency of fibrosar-
comas increased from 0% to around 10% of the over-
all tumour diagnoses. In the 1990s, fibrosarcoma
frequency increased to approximately 20% and has
remained stable ever since. A number of studies
have revealed an association between the use of inject-
able products, including vaccines against rabies and
feline leukaemia virus (FeLV) and the development
of sarcomas located at injection sites (feline injectionFig. 21. Odds ratios (ORs) and 95% confidence intervals (CIs) for t
cardiorespiratory system (n ¼ 1,050) compared with the Eursite sarcomas) (Hendrick and Goldschmidt, 1991;
Hendrick et al., 1992, 1994; Kass et al., 1993; Macy
and Hendrick, 1996). The inactivated animal rabies
vaccine was developed in the 1950s and 1960s
(Cabasso et al., 1965; Dietzgen and Kuzmin, 2012).
The first FeLV vaccine became available in
Switzerland in 1986 (Lutz, 1986). The substantial in-
crease in sarcomas, which started in the 1990s, might
therefore be related to the introduction of the FeLV
vaccine in Switzerland.
The data show that fibrosarcomas occurred more
frequently in middle-aged and older cats. There was
a small difference between sex and neutering status.
Significant differences were found between breeds.
Some breeds had odds of developing a fibrosarcoma
that were more than five times lower than those of
the European shorthair cat. Existing studies found
that fibrosarcomas mostly occur in older cats, with
no breed or sex predilection (Miller et al., 1991;
Goldschmidt and Shofer, 1992). The present study
is the first to reveal significant differences in the
development of fibrosarcomas in cats of different sex
and breed. This could be due to the high number of
animals in the study; however, further studies are
necessary to confirm these differences.
From the 1970s to the beginning of the 1990s, lym-
phoma was fairly frequent (up to 38%) compared
with other tumour types. In the 1990s, its frequency
decreased to around 10%. Many lymphomas were
caused by FeLV (Jarrett et al., 1964; Hardy, 1980).
The decrease in the frequency of lymphomas in thehe most common breeds that develop a malignant tumour in the
opean shorthair cat (OR ¼ 1).
Fig. 22. Relative diagnosis frequency of malignant tumours in the
oral cavity/pharynx (n¼ 862) expressed as a percentage of
overall tumour diagnoses between 1965 and 2008.
Fig. 23. Occurrence of the most commonmalignant tumour types
in the oral cavity/pharynx (n ¼ 862).
Fig. 24. Odds ratios (ORs) and 95% confidence intervals (CIs) for the
cavity/pharynx (n ¼ 862) compared with the European short
Swiss Feline Cancer Registry 2071990s could therefore be explained by the
introduction of the FeLV vaccine into Switzerland
(Lutz, 1986).
The results show that the mean age for developing
lymphoma was 8.5 years. Contrary to other tumours,
lymphomas were also frequent in young cats. Neu-
tered cats had higher odds of developing lymphoma
compared with entire cats and male cats had higher
odds than females. Oriental shorthair and Somali
were the only breeds with a significantly higher
odds ratio than that of European shorthair cats.
Studies carried out in North America (Meincke
et al., 1972; Hardy, 1981), Australia (Sabine et al.,
1974) and Japan (Haga et al., 1988) found that lym-
phoma occurs at mean ages of 4e6 years. More recent
studies carried out in Australia (Court et al., 1997;
Gabor et al., 1998) and North America (Vail et al.,
1998; Louwerens et al., 2005) determined mean ages
between 8 and 11 years. High incidences of
lymphoma among young cats have also been
described in other studies (Dorn et al., 1968b; Sabine
et al., 1974; Gabor et al., 1998). A predisposition of
males has been described in some studies (Dorn et al.,
1968b; Court et al., 1997; Gabor et al., 1998; Vail
et al., 1998), while no association was found in others
(Meincke et al., 1972; Haga et al., 1988). No
predisposition of neutered cats has been described.
Siamese/Oriental breeds were found to be overrep-
resented in some studies (Court et al., 1997; Gabor
et al., 1998; Louwerens et al., 2005), while no breed
prevalence was found in others (Haga et al., 1988).
However, because of limited numbers of animals,most common breeds that develop a malignant tumour in the oral
hair cat (OR ¼ 1).
208 R. Graf et al.Siamese cats were pooled in a group with the Oriental
breeds in these studies.
Comparing the present data with other existing
studies on the most common tumour types in cats,
data on cutaneous tumours are in general agreement
(Bostock, 1986; Stiglmair-Herb, 1987; J€orger, 1988;
Miller et al., 1991). We show a higher frequency of
fibrosarcomas compared with the other study carried
out in Switzerland in 1988. This is due to the
increase in fibrosarcomas in the 1990s. In Germany,
the frequency of fibrosarcomas was already high
(43%) in 1987 (Stiglmair-Herb, 1987).
A lower frequency of lymphomas in the gastrointes-
tinal tract was seen in the present study compared
with others (Cotchin, 1952; Patnaik et al., 1975;
Rissetto et al., 2011). The reason for the relatively
small number of lymphomas in the gastrointestinal
tract could be because information on the location
of most lymphomas was missing. Another reason
could be that these tumours might have been
classified as something other than lymphoma when
the tumour involved viscera other than the intestine.
Adenocarcinoma as the most frequent tumour type
in the lung/bronchus and squamous cell carcinoma as
the most frequent tumour type in the oral cavity/
pharynx have also been described by other investiga-
tors (Patnaik et al., 1975; Dorn and Priester, 1976;
Stebbins et al., 1989; Hahn and McEntee, 1997;
Meuten, 2002; D’Costa et al., 2012).
The high number of cats and the long study period
in the present investigation allowed us to show the
relative frequency of feline tumours over time. To
our knowledge, there is no other study that has pub-
lished comparable numbers. Changes in frequency
could reveal environmental influences. However,
the time-dependent differences in the prevalence of
certain tumours, particularly those with an irregular
course, may reveal biases in changed detection
methods or success in countermeasures/preventive
measures, such as vaccination. Further studies and
analysis would elucidate such courses in detail.
The frequency of tumour development increases
with age for all tumour types and tumour locations.
Mean ages calculated in the present study all corre-
spond well with the mean ages calculated in other
studies (Cotchin, 1952, 1961; Dorn et al., 1968b;
Hayden, 1971; Weijer et al., 1972; Stuenzi et al.,
1974; Patnaik et al., 1975; Hayes et al., 1981;
Moulton et al., 1981; Stiglmair-Herb, 1987; J€orger,
1988; Stebbins et al., 1989; Ito et al., 1996; Hahn
and McEntee, 1997; Rissetto et al., 2011).
The present study revealed higher odds of devel-
oping a tumour in neutered cats than in entire cats
for many tumour types and tumour locations; howev-
er, differences were sometimes very small. Higher oddsin entire cats compared with neutered cats were only
found for females and mammary gland tumours.
Few studies have analysed the differences between
neutered and entire cats except for investigations of
mammary neoplasia. The increased risk for neoplasia
in this organ system in entire cats has been described
in several studies. The benefit of neutering appears to
be dependent on the age at which the procedure is
performed (Dorn et al., 1968b; Hayes et al., 1981;
Misdorp et al., 1991; Overley et al., 2005). Cotchin
(1952) and Rissetto et al. (2011) described a higher
risk for neutered animals of developing a tumour in
the intestine. We found that females had higher
odds compared with males of developing adenomas/
adenocarcinomas (all tumours and malignant tu-
mours only) and tumours in the skin/subcutis (malig-
nant tumours), mammary gland, cardiorespiratory
system and lung/bronchus. Males had higher odds
compared with females for the oral cavity/pharynx.
Other studies found no sex differences for squamous
cell carcinoma (all locations) and for all tumours in the
skin/subcutis (Cotchin, 1961; Stiglmair-Herb, 1987;
J€orger, 1988). Sex predilection is controversial
regarding feline gastrointestinal, lung/bronchus and
oral cavity/pharyngeal tumours. Some studies note a
male overrepresentation in gastrointestinal tumours
and others report equal representation between the
sexes (Cotchin, 1952; Patnaik et al., 1975; Turk et al.,
1981; Rissetto et al., 2011). Higher frequencies in
females were found by Patnaik et al. (1975) in the lung/
bronchus and oral cavity/pharynx. Equal rates were
describedbyD’Costa et al. (2012)andDorn et al. (1968b).
In contrast to the higher number of patient records
in the present study, other studies grouped feline
breeds according to a limited numbers of case records.
Only approximate comparisons are therefore possible.
In the present study, several breeds had much lower
odds ratios for developing squamous cell carcinoma
compared with European shorthair cats. Miller et al.
(1991) found that Siamese cats had fewer squamous
cell carcinomas than expected, although this differ-
ence was not statistically significant. An increased
risk in European shorthair and a decreased risk in Si-
amese, Himalayan and Persian cats was reported by
Goldschmidt and Hendrick (2002).
In the present study, several breeds had significantly
higher odds ratios for developing a tumour in themam-
mary gland compared with the European shorthair
cat. The highest odds ratios were shown for Oriental
shorthair, Somali, Abyssinian and Siamese cats. An
overrepresentation among Siamese cats was described
by two other studies (Hayes et al., 1981; Ito et al., 1996).
Siamese cats had significantly higher odds of devel-
oping amalignant tumour of the gastrointestinal tract
and Siamese, Chartreux and Somali cats had
Swiss Feline Cancer Registry 209significantly higher odds of developing a tumour in
the intestines compared with the European shorthair
cat. An overrepresentation among Siamese cats was
described in several studies (Patnaik et al., 1975;
Turk et al., 1981; Cribb, 1988; Rissetto et al., 2011).
Nobreedpredispositionwas found for tumours of the
lung/bronchus. No breed predispositions were reported
in other studies, except for one that described Persian
cats as being overrepresented (D’Costa et al., 2012).
In conclusion, this study has focused on the most
frequent tumour types and tumour locations diag-
nosed in cats between 1965 and 2008 and the possible
influence of sex, age and breed. The sampling period
of more than 40 years allowed us to construct a
comprehensive retrospective feline cancer registry.
Compared with existing studies of feline tumours,
most results are similar, but some contradict other
studies and for some results there was no comparison.
Since in many studies different methodologies, inclu-
sion criteria, tumour classifications and statistical an-
alyses were used, it would be desirable to define for
future studies, international standards for animal can-
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